Biologics Global Market Competitor Briefing 2021
Report Highlights
Including: Monoclonal Antibodies (MAbS); Therapeutic Proteins; Vaccines
Covering: AbbVie; Johnson & Johnson; Amgen; Sanofi S.A; F. Hoffmann-La Roche Ltd.
AbbVie was the largest competitor with 8.74% of the market followed by Johnson & Johnson and Amgen
Biologics Global Market Competitor Briefing 2021 provides strategists, marketers and senior management with the critical information they need to assess the global Biologics sector.
Reasons to Purchase
- Fully updated for 2021 including the impact of the Covid 19/ Novel Coronavirus.
- Identify growth segments and opportunities.
- Facilitate decision making on the basis of historic and forecast data and key trends
- Develop strategies based on likely future developments.
- Gain a global perspective on the development of the market.
Description
- Biologics Global Market Competitor Briefing 2021 from the Business Research Company covers market characteristics, size and growth, market shares, trends and strategies for this market.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the Biologics market revenues, covering both the historic growth of the market and forecasting the future.
- Biologics market.
Scope
Markets Covered: Monoclonal Antibodies (MAbS); Therapeutic Proteins; Vaccines
Companies Mentioned: AbbVie; Johnson & Johnson; Amgen; Sanofi S.A; F. Hoffmann-La Roche Ltd.
Geographic scope: Asia Pacific, North America, Western Europe, Eastern Europe, South America, Middle East, Africa
Countries: Australia, China, Hong Kong, India, Indonesia, Japan, South Korea, Malaysia, New Zealand, Philippines, Singapore, Thailand, Vietnam, Canada, USA, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela, Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, the UK, Czech Republic, Poland, Romania, Russia, Israel, Saudi Arabia, Turkey, UAE, Egypt, Nigeria, South Africa
Time series: Five years historic and forecast
Data: Market value in $ billions.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Table 1 : Global Biologics Market, Historic Market Size, 2015-2020, $ Billion
- Table 2 : Global Biologics Market, Forecast Market Size, 2020-2025, $ Billion
- Table 3 : Global Biologics Market, Key Competitors Estimated Market Shares, 2020, Percentage (%)
- Table 4 : AbbVie – Financial Performance, $ Billion
- Table 5 : J&J– Financial Performance, $Billion
- Table 6 : Amgen – Financial Performance, $ Billion
- Table 7 : Biologics Market Data Sources
- Figure 1 : Global Biologics Market, Historic Market Size, 2015-2020, $ Billion
- Figure 2 : Global Biologics Market, Forecast Market Size, 2020-2025, $ Billion
- Figure 3 : Global Biologics Key Competitor Estimated Market Shares, 2020, Percentage (%)
- Figure 4 : AbbVie – Financial Performance, $ Billion
- Figure 5 : J&J – Financial Performance, $ Billion
- Figure 6 : Amgen – Financial Performance, $ Billion
The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.
Similar Reports from TBRC (Publisher)
Biologics Investment Competitor Outlook 2020: Covid 19 Impact and Recovery
Including: Monoclonal Antibodies (MAbS); Therapeutic Proteins; Vaccines
Covering: AbbVie; Johnson & Johnson; F. Hoffmann-La Roche Ltd.; Amgen; Merck & Co
AbbVie was the largest competitor with 7.41% of the market followed by Johnson & Johnson and F. Hoffmann-La Roche Ltd.
Biologics Investment Competitor Outlook 2020: Covid 19 Impact and Recovery provides strategists, marketers and senior management with the ...
Biologics Market Global Briefing 2020: Covid 19 Impact and Recovery
Including: Monoclonal Antibodies (MAbS); Therapeutic Proteins; Vaccines
Biologics Market Competitor Briefing 2019
Including: Monoclonal Antibodies (MAbS); Therapeutic Proteins; Vaccines
Covering: F. Hoffmann-La Roche Ltd.; Johnson & Johnson; AbbVie Inc.; Merck & Co.; Amgen
Research Methodology
The report is built on information collected through secondary sources and analysis done by The Business Research
Company (TBRC). The secondary sources include the data published by statistical bodies, government agencies, market
intelligence databases and annual reports. ...
Biologics Market Global Briefing 2019
Research Methodology
The report is built on information collected through secondary sources and analysis done by The Business Research Company (TBRC). The secondary sources include the data published by statistical bodies, government agencies, market intelligence databases and annual reports. Insights on the current market scenario, historic and forecast market drivers were gathered from industry reports and news articles.
Note on ...
Biologics Market Global Briefing 2018
Including: Therapeutic Proteins, Monoclonal Antibodies (MAbS), Vaccines.
Covering: Amgen, AbbVie And Johnson & Johnson
Research Methodology
The Business Research Company’s reports are based on the methodology below.
Data –
Our datasets are created using a wide range of proprietary and public sources including leading government bodies, associations, regulatory agencies, scientific journals and market intelligence reports. Data is modelled based on ...
Biologics Market Global Briefing 2017
Including: Therapeutic Proteins, Monoclonal Antibodies (MAbS), Vaccines.
Covering: Amgen, AbbVie, Johnson & Johnson, Bristol-Myers Squibb Company, Pfizer, Eli Lilly, F. Hoffmann-La Roche Ltd, Merck & Co., GlaxosmithKline, Sanofi
Research Methodology
The Business Research Company’s reports are based on the methodology below.
Data
Our datasets are created using a wide range of proprietary and public sources including leading government bodies, associations, ...